CLYM ▼ -3.3% - Climb Bio, Inc.
$CLYM - Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
24-OCT-2026 07:30 PM ET
Share this post
More filings for $CLYM
CLYM - Climb Bio, Inc. - SEC Filing Update (09-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 9, 2026CLYM - Climb Bio, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026CLYM ▲ +4.0% - Climb Bio, Inc.Nov 5, 2026CLYM ▲ +0.1% - Climb Bio, Inc.Nov 4, 2026CLYM - Climb Bio, Inc. - SEC Filing Update (28-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 28, 2026CLYM - Climb Bio, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026
View full $CLYM filing history →💬 Comments
Loading comments…
Leave a comment